Literature DB >> 1642836

Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media.

S Esposito1, S Noviello, G D'Errico, C Montanaro.   

Abstract

Clinical and bacteriological efficacy of topical ciprofloxacin hydrochloride was compared with that of intramuscular gentamicin sulfate in two groups composed of 30 patients each, all of whom were affected by chronic otitis media in the acute stage. Antibiotics were randomly given for 5 to 10 days according to the following schedules: ciprofloxacin hydrochloride, four drops (250 mg/mL in saline solution) administered locally twice a day, or gentamicin sulfate, 80 mg administered intramuscularly twice a day. We admitted to the study only adult patients affected by chronic otitis media in the acute stage with perforation of the tympanic membrane, without cholesteatoma, whose bacteriological culture was positive for Pseudomonas susceptible in vitro to ciprofloxacin and gentamicin. The clinical and bacteriological response was stated 12 hours after the interruption of the treatment, and 2 and 3 weeks later (follow-up). A favorable clinical result was observed in 26 (87%) of 30 patients under ciprofloxacin treatment; in 30 patients receiving gentamicin, a favorable clinical response was observed in 20 (66%) and bacteriological eradication in 13 (43%). No relapse at the follow-up was observed. Topical ciprofloxacin seems to be more effective than intramuscular gentamicin in curing Pseudomonas-caused chronic otitis media in the acute stage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642836     DOI: 10.1001/archotol.1992.01880080064014

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  12 in total

1.  In vitro efficacy of the successive or staggered use of eardrops.

Authors:  M Tayyar Kalcioglu; Orhan Ozturan; Riza Durmaz; Elif Aktas
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

Review 2.  Chronic suppurative otitis media.

Authors:  Jose Acuin
Journal:  BMJ Clin Evid       Date:  2007-02-01

Review 3.  Chronic suppurative otitis media.

Authors:  Peter Morris
Journal:  BMJ Clin Evid       Date:  2012-08-06

Review 4.  Systemic antibiotics for chronic suppurative otitis media.

Authors:  Lee-Yee Chong; Karen Head; Katie E Webster; Jessica Dew; Peter Richmond; Tom Snelling; Mahmood F Bhutta; Anne Gm Schilder; Martin J Burton; Christopher G Brennan-Jones
Journal:  Cochrane Database Syst Rev       Date:  2021-02-04

5.  Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin.

Authors:  A Altuntas; A Aslan; N Eren; A Unal; Y Nalca
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 6.  A benefit-risk assessment of ofloxacin otic solution in ear infection.

Authors:  Talen K H Wai; Michael C F Tong
Journal:  Drug Saf       Date:  2003       Impact factor: 5.228

7.  Topical versus systemic antibiotics for chronic suppurative otitis media.

Authors:  Lee-Yee Chong; Karen Head; Katie E Webster; Jessica Daw; Peter Richmond; Tom Snelling; Mahmood F Bhutta; Anne Gm Schilder; Martin J Burton; Christopher G Brennan-Jones
Journal:  Cochrane Database Syst Rev       Date:  2021-02-09

8.  Topical antibiotics for chronic suppurative otitis media.

Authors:  Christopher G Brennan-Jones; Karen Head; Lee-Yee Chong; Martin J Burton; Anne Gm Schilder; Mahmood F Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2020-01-02

9.  Topical antiseptics for chronic suppurative otitis media.

Authors:  Karen Head; Lee-Yee Chong; Mahmood F Bhutta; Peter S Morris; Shyan Vijayasekaran; Martin J Burton; Anne Gm Schilder; Christopher G Brennan-Jones
Journal:  Cochrane Database Syst Rev       Date:  2020-01-06

10.  Antibiotics versus topical antiseptics for chronic suppurative otitis media.

Authors:  Karen Head; Lee-Yee Chong; Mahmood F Bhutta; Peter S Morris; Shyan Vijayasekaran; Martin J Burton; Anne Gm Schilder; Christopher G Brennan-Jones
Journal:  Cochrane Database Syst Rev       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.